Execs On The Move: C-Suite Changes at Nuvectra, Biogennix, Microbot
Executive Summary
An experienced board member steps up to fill the CEO slot at neurostim firm Nuvectra; a new CFO is taken on board at osteobiological products company Biogennix; and Microbot Medical's chief operating officer resigns.
You may also be interested in...
CDER Pilot Program Offers Potential New Pathway For Approval Of Novel Pharmaceutical Excipients
After decades without an approval pathway for excipients, FDA pilot program paves the way for innovation.
Novartis Looks To Take Its Diversity Show On The Road
Head of clinical trial diversity and inclusion Kim Fookes spoke with Scrip about Novartis’s US trial diversity initiatives and early plans to expand them abroad.
New Material Safety Reports Highlight Lack Of Data To Fully Evaluate Adverse Reactions
The US FDA and ECRI released four reports about the safety of certain materials used in medical devices. While the risks seem to be comparatively low, they note the quality of literature is lacking to make broad evaluations.